High DcR3 expression predicts stage pN2-3 in gastric cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 1, 2008, Pages 79-83

  Wu, Yulian ^a   Guo, Enqi ^a   Yu, Junxiu ^a   Xie, Qiuping ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

DcR3; Extended D2 lymphadenectomy; Gastric cancer; N staging

Indexed keywords

DECOY RECEPTOR 3; MESSENGER RNA; TNFRSF6B PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CLINICAL EVALUATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIMARY TUMOR; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; ADENOCARCINOMA; COMPARATIVE STUDY; GASTRECTOMY; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; ROC CURVE; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 42449083353     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3180ca77ad     Document Type: Article

References (29)

1. Boring CC, Squires TS, Tong T, et al. Cancer statistics, 1994. CA Cancer J Clin. 1994;44:7-26.
2. Sun XD, Mu R, Zhou YS, et al. Analysis of mortality rate of stomach cancer and its trend in twenty years in China [in Chinese]. Zhonghua Zhong Liu Za Zhi. 2004;26:4-9.
3. Meyer HJ, Jahne J. Lymph node dissection for gastric cancer. Semin Surg Oncol. 1999;17:117-124.
4. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000;26:243-255.
5. Kodama Y, Sugimachi K, Soejima K, et al. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg. 1981;5:241-248.
6. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987;11:418-425.
7. Roukos DH. Therapeutic value of D2-resection in gastric cancer evaluated with a new concept. UICC Consensus Conference. In: Kim JP, Min JS, Mok YJ, eds. Proceedings of the 3rd International Gastric Cancer Congress, Seoul, 1999. Bologna, Italy: Monduzzi Editore; 1999: 29-33.
8. Bunt AM, Hermans J, Smit VT, et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol. 1995;13:19-25.
9. Bonenkamp JJ, Hermans J, Sasako M, et al. Dutch Gastric Cancer Group: extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908-914.
10. Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol. 1999;6:46-56.
11. Whiting JL, Hallissey MT, Rowlands DC, et al. Redefining surgery for gastric cancer. Gastric Cancer. 1999;2:226-229.
12. Fukuya T, Honda H, Hayashi T, et al. Lymph node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology. 1995;197:705-711.
13. Wakelin SJ, Deans C, Crofts TJ, et al. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol. 2002;41:161-167.
14. Dittler HJ, Siewert JR. Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy. 1993;25:162-166.
15. Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991;81:426-432.
16. Ziegler K, Sanft C, Zimmer T, et al. Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut. 1993;34:604-610.
17. Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004;230:465-471.
18. Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 1998; 396:699-703.
19. Wu Y, Han B, Sheng H, et al. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients. Int J Cancer. 2003;105:724-732.
20. Sobin LH, Wittekind C. International Union Against Cancer: TNM Classification of Malignant Tumors, 5th ed. New York: Wiley; 1997: 59-62.
21. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English ed. Gastric Cancer. 1998;1:10-24.
22. Ko S, Chu KM, Luk JM, et al. Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun. 2004;319:562-568.
23. Ishii M, Gama H, Chida N, et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol. 2000;95:1036-1040.
24. Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem. 1999;274:13733-13736.
25. Migone TS, Zhang J, Luo X, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002; 16:479-492.
26. Mauri DN, Ebner R, Montgomery RI, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 1998;8:21-30.
27. Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer. 2002;5:61-68.
28. Bai C, Connolly B, Metzker ML, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA. 2000;97:1230-1235.
29. Hsu TL, Chang YC, Chen SJ, et al. Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J Immunol. 2002; 168:4846-4853.